{"id":"https://openalex.org/W4361847646","doi":"https://doi.org/10.1158/0008-5472.c.6510438.v1","title":"Data from Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck Cancer","display_name":"Data from Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361847646","doi":"https://doi.org/10.1158/0008-5472.c.6510438.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6510438.v1","doi":"https://doi.org/10.1158/0008-5472.c.6510438.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6510438.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6510438.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083547831","display_name":"Sri Krishna","orcid":"https://orcid.org/0000-0003-4994-3758","observed_orcids":["https://orcid.org/0000-0003-4994-3758"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sri Krishna","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4994-3758","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112888168","display_name":"Peaches Rebecca Ulrich","orcid":"https://orcid.org/0000-0002-0198-8773","observed_orcids":["https://orcid.org/0000-0002-0198-8773"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peaches Ulrich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006493309","display_name":"Eric Wilson","orcid":"https://orcid.org/0000-0002-4104-1445","observed_orcids":["https://orcid.org/0000-0002-4104-1445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Wilson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4104-1445","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037429407","display_name":"Falguni S Parikh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Falguni Parikh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111692876","display_name":"Pooja Narang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pooja Narang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100711727","display_name":"Shanshan Yang","orcid":"https://orcid.org/0000-0002-2392-6565","observed_orcids":["https://orcid.org/0000-0002-2392-6565"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shanshan Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011839013","display_name":"Amelia K. Read","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amelia K. Read","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054970583","display_name":"Seunghee Kim\u2010Schulze","orcid":"https://orcid.org/0000-0003-0192-4400","observed_orcids":["https://orcid.org/0000-0003-0192-4400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seunghee Kim-Schulze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051386656","display_name":"Jin G. Park","orcid":"https://orcid.org/0000-0001-6481-9590","observed_orcids":["https://orcid.org/0000-0001-6481-9590"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin G. Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090322942","display_name":"Marshall R. Posner","orcid":"https://orcid.org/0000-0003-1912-3281","observed_orcids":["https://orcid.org/0000-0003-1912-3281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marshall Posner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050513433","display_name":"Melissa A. Wilson Sayres","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa A. Wilson Sayres","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035973740","display_name":"Andrew Gregory Sikora","orcid":"https://orcid.org/0000-0002-8357-8435","observed_orcids":["https://orcid.org/0000-0002-8357-8435"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Sikora","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033246326","display_name":"Karen S. Anderson","orcid":"https://orcid.org/0000-0002-3870-5730","observed_orcids":["https://orcid.org/0000-0002-3870-5730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen S. Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.11490000039339066,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.021299999207258224,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hpv-16","display_name":"HPV16","score":0.9089999794960022},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8930000066757202},{"id":"https://openalex.org/keywords/ctl-epitopes","display_name":"CTL epitopes","score":0.8069999814033508},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7360000014305115},{"id":"https://openalex.org/keywords/ido1","display_name":"IDO1","score":0.8130000233650208},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.5239999890327454},{"id":"https://openalex.org/keywords/hpv-e7-antigen","display_name":"HPV E7 antigen","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hla-class-i-restriction","display_name":"HLA class I restriction","score":0.8629999756813049},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6516854763031006},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.6389287710189819},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5629695057868958},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.533432126045227},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4681648910045624},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46590882539749146},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.442905455827713},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.41875797510147095},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.41338348388671875},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4107345938682556},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3683253824710846},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12281191349029541},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07478475570678711}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6510438.v1","doi":"https://doi.org/10.1158/0008-5472.c.6510438.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6510438.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6510438.v1","doi":"https://doi.org/10.1158/0008-5472.c.6510438.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6510438.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2889134696","https://openalex.org/W4361847572","https://openalex.org/W2015657357","https://openalex.org/W2161424280","https://openalex.org/W7135918825","https://openalex.org/W2478804460","https://openalex.org/W1587588102","https://openalex.org/W2743923780","https://openalex.org/W3196420804","https://openalex.org/W7053211108"],"abstract_inverted_index":{"Abstract":[0],"Human":[1],"papillomavirus":[2],"subtype":[3],"16":[4,51],"(HPV16)":[5],"is":[6],"the":[7,243,257],"primary":[8],"cause":[9],"of":[10,14,36,46,104,119,185,200,211,228,249,260,268,277],"an":[11],"increasing":[12],"number":[13],"head":[15],"and":[16,42,53,62,93,112,117,143,159,209,252,264],"neck":[17],"squamous":[18],"cell":[19],"carcinomas":[20],"(HNSCC),":[21],"providing":[22],"strong":[23,52],"rationale":[24],"for":[25,236],"T-cell":[26,47,110,124,186,246],"immune":[27,201],"therapies":[28],"against":[29],"HPV+":[30,80,115,135,166,189,229,278],"HNSCC.":[31,279],"Here":[32],"we":[33],"assess":[34],"immunogenicity":[35,247],"HPV16-specific":[37],"CD8+":[38],"T":[39],"cells":[40,206],"(CTL)":[41],"characterize":[43],"HPV-specific":[44,212],"mechanisms":[45,184],"dysfunction.":[48],"We":[49],"identified":[50,220],"29":[54],"moderately":[55],"immunogenic":[56],"CTL-epitopes":[57,219],"from":[58],"HPV16":[59,218],"E2,":[60,91],"E6,":[61,92],"E7":[63,94,146],"antigens":[64],"restricted":[65],"by":[66],"12":[67],"common":[68],"HLA":[69],"class":[70],"I":[71],"alleles.":[72],"E2-specific":[73],"CTL-reactivity":[74],"was":[75,131],"higher":[76],"in":[77,83,99,114,134,171,176,188,197,221,224,256],"patients":[78],"with":[79,123,145,156,226],"HNSCC":[81,106,116,136,139,167],"than":[82],"healthy":[84],"controls":[85],"(>3-fold;":[86],"P":[87,151,178],"=":[88,141,149,152,179],"0.026).":[89],"Patient-derived":[90],"peripheral":[95],"CTLs":[96,213,263],"exhibited":[97],"heterogeneity":[98],"dysfunctional":[100],"phenotypes.":[101],"Immunogenomic":[102],"analyses":[103],"119":[105],"transcriptomes":[107],"revealed":[108],"high":[109,192,198],"infiltration":[111],"dysfunction":[113,202,210],"correlation":[118],"HPV":[120,244,261],"antigen":[121,245],"expression":[122,147,199],"exhaustion":[125,254],"gene":[126],"signatures.":[127],"Indoleamine":[128],"2,3-dioxygenase":[129],"(IDO-1)":[130],"strongly":[132],"expressed":[133],"versus":[137],"HPV\u2212":[138],"(P":[140],"0.001)":[142],"correlated":[144],"(R2":[148],"0.84;":[150],"0.033).":[153],"Combination":[154],"treatment":[155],"PD-1":[157],"blockade":[158,227],"IDO-1":[160],"inhibition":[161,267],"overcame":[162],"profound":[163],"CTL-dysfunction,":[164],"enhancing":[165],"sensitivity":[168],"to":[169,174,273],"CTL-cytotoxicity":[170],"vitro":[172],"(up":[173],"10-fold":[175],"E7-CTLs,":[177],"0.011).":[180],"Our":[181],"findings":[182],"implicate":[183],"escape":[187],"HNSCC,":[190],"wherein":[191],"tumoral":[193],"HPV-antigen":[194],"load":[195],"results":[196],"genes":[203],"on":[204],"tumor":[205],"(e.g.,":[207,214],"IDO-1),":[208],"E7,":[215],"E2-CTLs).":[216],"The":[217],"this":[222],"study,":[223],"combination":[225],"HNSCC-specific":[230],"PD-1/IDO-1":[231,269],"checkpoints,":[232],"may":[233],"be":[234],"useful":[235],"targeted":[237],"immunotherapy.":[238],"Significance:":[239],"This":[240],"study":[241],"evaluates":[242],"role":[248],"inhibitory":[250],"receptors":[251],"other":[253],"markers":[255],"cytotoxic":[258],"function":[259],"antigen-specific":[262],"identifies":[265],"combined":[266],"as":[270],"a":[271],"strategy":[272],"enhance":[274],"CTL":[275],"targeting":[276],"Cancer":[280],"Res;":[281],"78(21);":[282],"6159\u201370.":[283],"\u00a92018":[284],"AACR.":[285]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}